MedPath

Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers

Not Applicable
Recruiting
Conditions
PTSD
Interventions
Behavioral: Clinician Supported PTSD Coach App
Behavioral: Prolonged Exposure for Primary Care (PE-PC)
Behavioral: Full Prolonged Exposure
Registration Number
NCT05457985
Lead Sponsor
University of Michigan
Brief Summary

This trial is being completed to develop a stepped-care talk therapy model for patients with PTSD. Specifically, this study is testing whether beginning with one type of therapy is better than beginning with another type of therapy, and whether moving to a different therapy after four sessions is more helpful than staying with the same therapy, depending on how well it is working.

The central hypothesis is that beginning with a low- or medium-intensity PTSD intervention and then titrating intensity based on early indications of response will result in clinically significant PTSD symptom reduction with parsimony of resources.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
430
Inclusion Criteria
  • Receive care at a participating federally qualified health center (FQHC)
  • Have a Posttraumatic Stress Disorder checklist (PCL-5) score greater or equal (≥) to 33
  • Own a mobile device that can be used for the PTSD Coach App
  • Have had psychotropic medication stability for at least 4 weeks
Exclusion Criteria
  • Severe cognitive impairment that in the judgment of the investigators makes it unlikely that the participant can adhere to the study regimen (as evidenced by confusion, inability to track discussion or answer questions, or other clear and significant indicators of cognitive impairment)
  • High risk of suicide (defined as meeting criteria for Action Step 3 on the Participant Suicide Risk Screening form
  • Severe alcohol or substance use disorder (moderate-severe alcohol use disorder on Alcohol Use Disorders Identification Test (AUDIT) (scores ≥ 15) or high risk on National Institute on Drug Abuse Quick Screen (scores ≥ 27))
  • Active psychosis or unmanaged bipolar disorder
  • Unstable housing
  • Current engagement in a trauma-focused behavioral treatment (such as Prolonged Exposure or Cognitive Processing Therapy).
  • Patients who do not speak English will be excluded for logistical reasons.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Clinician Supported (CS) PTSD Coach App then continue as early responderClinician Supported PTSD Coach AppDuring the first stage of treatment, participants will receive four weekly clinician support sessions or 9 weeks (whichever occurs first). Early responders will be encouraged to continue app use but will discontinue clinician support sessions for 8 weeks.
Prolonged Exposure for Primary Care (PE-PC) then full PEProlonged Exposure for Primary Care (PE-PC)PE-PC consists of four weekly 30-minute sessions. At the 4th session or 9-week assessment point (whichever comes first), slow responders that are then randomized to full PE will have sessions once a week for eight weeks. During these 60 minute sessions, participants will practice in vivo and imaginal exposure and continue these exposure exercises every day at home.
Clinician Supported PTSD Coach App then full PEClinician Supported PTSD Coach AppDuring the first stage of treatment, participants will receive four weekly clinician support sessions or 9 weeks (whichever occurs first), slow responders that are then randomized to full PE will have sessions once a week for eight weeks. During these 60 minute sessions, participants will practice in vivo and imaginal exposure and continue these exposure exercises every day at home.
Prolonged Exposure for Primary Care (PE-PC) then full PEFull Prolonged ExposurePE-PC consists of four weekly 30-minute sessions. At the 4th session or 9-week assessment point (whichever comes first), slow responders that are then randomized to full PE will have sessions once a week for eight weeks. During these 60 minute sessions, participants will practice in vivo and imaginal exposure and continue these exposure exercises every day at home.
Prolonged Exposure for Primary Care (PE-PC) then continued PE-PCProlonged Exposure for Primary Care (PE-PC)PE-PC consists of four weekly 30-minute sessions. At the 4th session or 9-week assessment point (whichever comes first), slow responders that are then randomized to continue with PE-PC (medium intensity) will continue weekly sessions for 8 weeks.
Prolonged Exposure for Primary Care (PE-PC) then continue as early responderProlonged Exposure for Primary Care (PE-PC)PE-PC consists of four weekly 30-minute sessions. At the 4th session or 9-week assessment point (whichever comes first), early responders will step down to every-other-week sessions for the duration of the second stage (for 8 weeks).
Clinician Supported PTSD Coach App then full PEFull Prolonged ExposureDuring the first stage of treatment, participants will receive four weekly clinician support sessions or 9 weeks (whichever occurs first), slow responders that are then randomized to full PE will have sessions once a week for eight weeks. During these 60 minute sessions, participants will practice in vivo and imaginal exposure and continue these exposure exercises every day at home.
Clinician Supported PTSD Coach App then continued CS PTSD Coach AppClinician Supported PTSD Coach AppDuring the first stage of treatment, participants will receive four weekly clinician support sessions or 9 weeks (whichever occurs first), slow responders that are then randomized to continue this treatment will have the frequency reduced to twice monthly.
Primary Outcome Measures
NameTimeMethod
Change in PTSD symptoms as measured by the Clinician-Administered PTSD Scale for Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 (CAPS-5)Baseline, 3-months

The CAPS-5 is a clinician-rated PTSD rating scale consisting of 30 items; the total score is calculated as the sum of 20 items assessing the 20 DSM-5 PTSD symptoms. These symptom items are scored on a 5-point scale from 0 (absent) to 4 (extreme/incapacitating). The total score of the 20 items ranges from 0 to 80 with higher scores indicating more severe PTSD symptoms. Therefore, a decrease in the total score indicates symptom improvement.

Secondary Outcome Measures
NameTimeMethod
Change in depressive symptoms measured by the Patient Health Questionnaire (PHQ-9)Baseline, 3-months

There are 9 questions that reflects the overall functioning and impairment due to the depressive symptoms. Scores ranges from 0 to 27, with a higher score indicating more severe symptoms.

Change in quality of life and functioning measured by the EuroQol-5 Domain (EQ-5D-5L)Baseline, 3-months

The EQ-5D-5L assesses patients' overall quality of life and health. This measure asks questions related to mobility, self-care, activity, pain, and anxiety/depression. Each dimension has five response levels: no problems, slight problems, moderate problems, severe problems, unable to /extreme problems. The participant indicates his/her health state by checking the box next to the most appropriate response level for each of the five dimensions. Higher scores mean better quality of life. Minimum score is 1 and the maximum score is 5 for each dimension. The measure also includes one 0-100 scale assessing how patients perceive their overall health.

Change in PTSD symptoms by the PTSD Checklist (PCL-5)Baseline, 3-months

The PTSD Checklist for DSM-5 (PCL-5) is a 20-item self-report measure that assesses symptoms of PTSD. The PCL-5 has a variety of purposes, including monitoring symptom change during and after treatment. The minimum score is 0, the maximum is 80 (higher scores indicate increased PTSD severity).

Trial Locations

Locations (13)

Family Health Care

🇺🇸

Baldwin, Michigan, United States

Grace Health

🇺🇸

Battle Creek, Michigan, United States

Genesee Community Health Center

🇺🇸

Flint, Michigan, United States

Hamilton Community Health Network

🇺🇸

Flint, Michigan, United States

Cherry Health

🇺🇸

Grand Rapids, Michigan, United States

MidMichigan Community Health Services

🇺🇸

Houghton Lake, Michigan, United States

Sterling Area Health Center

🇺🇸

Sterling, Michigan, United States

Upper Great Lakes Family Health Care Center

🇺🇸

Menominee, Michigan, United States

Family Medical Center of Michigan

🇺🇸

Monroe, Michigan, United States

Family Care Health Centers

🇺🇸

Saint Louis, Missouri, United States

CommUnityCare Health Centers

🇺🇸

Austin, Texas, United States

Western North Carolina Community Health Services

🇺🇸

Asheville, North Carolina, United States

Unity Care NW

🇺🇸

Bellingham, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath